[SARS-CoV-2 infection in a patient treated by hydroxychloroquine and anti TNF α for Inflammatory Rheumatic Disease]. / Une infection par le SARS-CoV-2 chez un patient sous hydroxychloroquine et anti TNF α pour rhumatisme inflammatoire chronique.
Pan Afr Med J
; 35(Suppl 2): 134, 2020.
Article
in French
| MEDLINE | ID: covidwho-926732
ABSTRACT
Hydroxychloroquine is an agent used as a treatment but also considered as a prophylaxis for SARS-CoV-2 infection. We report the case of a patient who developed COVID-19 while on hydroxychloroquine for mixed connectivitis associated with spondyloarthritis. Although more work is needed before any conclusions can be drawn, this raises questions about the protective role of this drug against infection. Are they really protected against COVID-19 or will they develop pauci-symptomatic forms?
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Pneumonia, Viral
/
Urticaria
/
Tumor Necrosis Factor-alpha
/
Skin Diseases, Viral
/
Coronavirus Infections
/
Antirheumatic Agents
/
Spondylarthropathies
/
Etanercept
/
Betacoronavirus
Type of study:
Case report
Topics:
Long Covid
Limits:
Adult
/
Humans
/
Male
/
Young adult
Language:
French
Journal:
Pan Afr Med J
Year:
2020
Document Type:
Article
Affiliation country:
Pamj.supp.2020.35.134.25011
Similar
MEDLINE
...
LILACS
LIS